IMP A SDB — Implantica AG Cashflow Statement
0.000.00%
Last trade - 00:00- SEK54.37bn
- SEK53.82bn
- €2.07m
Annual cashflow statement for Implantica AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.5 | -21.4 | -24.5 | -23.7 | -19.8 |
| Depreciation | |||||
| Non-Cash Items | 2.4 | 3.69 | 2.7 | -1.53 | 0.873 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.188 | 0.019 | 0.268 | -0.837 | -0.41 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -11.5 | -16 | -19.9 | -22.8 | -16.6 |
| Capital Expenditures | -5.44 | -9.3 | -3.83 | -0.442 | -0.072 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -46.2 | 50.4 | 0.675 | 0.787 | -28.2 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -51.6 | 41.1 | -3.15 | 0.345 | -28.2 |
| Financing Cash Flow Items | 55.6 | -0.3 | -0.027 | -0.048 | -0.012 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 48.1 | -0.937 | -0.431 | -0.305 | -0.191 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -13.2 | 24.6 | -21 | -23.4 | -44.7 |